News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
BIOLAN
BIOLAN HEALTH takes over the presidency of the BASQUE HEALTH CLUSTER
Corporate
At the Basque Health Cluster Assembly held on 9 June, the renewal of the Board of Directors was…
jjj
Life Length obtains European authorization for its innovative prostate cancer diagnostic test, PROSTAV®
PROSTAV® tiene por objeto mejorar sustancialmente el diagnóstico de cáncer de próstata; el más…
genesis
GENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of the National Awards El Suplemento
Corporate
Last May 19th GENESIS Biomed received the award to the best biomedical consultancy of the XI…
Ysios
Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension
Corporate
Derek DiRocco of RA Capital Management and Olivier Litzka, PhD of Andera Partners Join Mineralys…
ORYZON
ORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Small Cell Lung Cancer
Healthcare · Access to innovation · Corporate
Now has orphan drug designation for SCLC and AML
mncn
AseBio and MNCN-CSIC bring together nearly 1,000 people to raise awareness of role science plays in protecting the planet
Climate change · Agrifood · Industrial biotechnology
This 2022 Environment Week also falls under the framework of the European Climate Pact, for which…
Natac Singapore office
Natac opens new Singapore office to locally serve its APAC customers
Access to innovation · International · BioSpain · Communication · Corporate
Madrid, Wednesday, June 1st, 2022— Natac has opened an office in central Singapore, to…
Orizon
ORYZON awarded EU Seal of Excellence and public financing of 2 M USD to develop iadademstat in Acute Myeloid Leukemia
Corporate
Non-refundable funds from the Next Generation-EU program
Víctor Vallés, fundador y CEO de Vesismin Health
Vesismin creates pioneering programme with comprehensive approach to hospital infections
Healthcare
Vesismin offers hospitals and health centres Vesismin Services, the first comprehensive programme…